Dandelion (Taraxacum officinale) flower ethanol extract inhibits cell proliferation and induces apoptosis in human ovarian cancer SK-OV-3 cells

Food Science and Biotechnology

Volumn 18, Issue 2, 2009, Pages 552-555

  Choi, Eun Jeong ^a   Kim, Gun Hee ^a  

^a Duksung Women's University   (South Korea)

Author keywords

Apoptosis; Cell proliferation; Dandelion; Taraxacum officinale

Indexed keywords

ANTICANCER PROPERTIES; ANTIPROLIFERATIVE EFFECT; APOPTOSIS; APOPTOSIS INDUCTION; APOPTOTIC CELL DEATH; CELL CYCLE; DANDELION; DOSE-DEPENDENT MANNER; DOWN-REGULATION; ETHANOL EXTRACT; OVARIAN CANCERS; PRO-APOPTOTIC EFFECTS; TARAXACUM OFFICINALE; UP-REGULATION;

CELL PROLIFERATION; DISEASES; ETHANOL;

CELL DEATH;

TARAXACUM OFFICINALE;

EID: 79954482613     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kummalue T. Molecular mechanism of herbs in human lung cancer cells. J. Med. Assoc. Thai. 88: 1725-1734 (2005)
2. Taixiang W, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst. Rev. 25: CD004540 (2005)
3. Ahn DK. Illustrated Book of Korean Medical Herbs. Kyohak Publishing Co., Seoul, Korea. pp. 134-135 (1998)
4. Koo HN, Hong SH, Song BK, Kim CH, Yoo YH, Kim HM. Taraxacum officinale induces cytotoxicity through TNF-alpha and IL-1alpha secretion in Hep G2 cells. Life Sci. 74: 1149-1157 (2004)
5. Schütz K, Kammerer DR, Carle R, Schieber A. Characterization of phenolic acids and flavonoids in dandelion (Taraxacum officinale WEB. ex WIGG.) root and herb by high-performance liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass. Sp. 19: 179-186 (2005).
6. Guarrera PM. Traditional phytotherapy in Central Italy (Marche, Abruzzo, and Latium). Fitoterapia 76: 1-25 (2005)
7. Rodriguez-Fragoso L, Reyes-Esparza J, Burchiel SW, Herrera-Ruiz D, Torres E. Risks and benefits of commonly used herbal medicines in Mexico. Toxicol. Appl. Pharm. 227: 125-135 (2008)
8. Hu C, Kitts DD. Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells. Mol. Cell. Biochem. 265: 107-113 (2004)
9. Hu C, Kitts DD. Dandelion (Taraxacum officinale) flower extract suppresses both reactive oxygen species and nitric oxide and prevents lipid oxidation in vitro. Phytomedicine 12: 588-597 (2005)
10. Baba K, Abe S, Mizuno D. Antitumor activity of hot water extract of dandelion, Taraxacum officinale-correlation between antitumor activity and timing of administration. Yakuga. Zasshi 101: 538-543 (1981)
11. Sigstedt SC, Hooten CJ, Callewaert MC, Jenkins AR, Romero AE, Pullin MJ, Kornienko A, Lowrey TK, Slambrouck SV, Steelant WF. Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells. Int. J. Oncol. 32: 1085-1090 (2008)
12. Le Marchand L. Cancer preventive effects of flavonoids-a review. Biomed. Pharmacotherapy 56: 296-301 (2002)
13. Ren W, Qiao Z, Wang H, Zhu L, Zhang L. Flavonoids: Promising anticancer agents. Med. Res. Rev. 23: 519-534 (2003)
14. Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, Lee MT. The antitumor activities of flavonoids. In Vivo 19: 895-909 (2005)
15. Sun SY, Hail N Jr, Lotan R. Apoptosis as a novel target for cancer chemoprevention. J. Natl. Cancer Inst. 5: 662-672 (2004)
16. Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 5: 876-885 (2005)
17. Benavente-García O, Castillo J. Update on uses and properties of citrus flavonoids: New findings in anticancer, cardiovascular, and anti-inflammatory activity. J. Agr. Food Chem. 56: 6185-6205 (2008)
18. Jones J, Lagasse LD, Karlan BY. Steroid hormonal independence of HER-2/neu mRNA expression in four human ovarian carcinoma cell lines. Gynecol. Oncol. 53: 421-426 (1994)
19. Lau KM, Mok SC, Ho SM. Expression of human estrogen receptoralpha-receptoralpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. P. Natl. Acad. Sci. USA 96: 5722-5727 (1999)
20. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. P. Natl. Acad. Sci. USA 92: 8493-8497 (1995)
21. Park M, Chae HD, Yun J, Jung M, Kim YS, Kim SH, Han MH, Shin DY. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest. Cancer Res. 60: 542-545 (2000)
22. Lepik D, Jaks V, Kadaja L, Varv S, Maimets T. Electroporation and carrier DNA cause p53 activation, cell cycle arrest, and apoptosis. Anal. Biochem. 318: 52-59 (2003)
23. Parker MA, Anderson JK, Corliss DA, Abraria VE, Sidman RL, Park KI, Teng YD, Cotanche DA, Snyder EY. Expression profile of an operationally-defined neural stem cell clone. Exp. Neurol. 194: 320-332 (2005)
24. Niculescu AB, Chen X, Smeets M, Hengst L, Prives C, Reed SI. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18: 629-643 (1998)
25. May P, May E. Twenty years of p53 research: Structural and functional aspects of the p53 protein. Oncogene 18: 7621-7636 (1999)
26. Bai F, Matsui T, Ohtani-Fujita N, Matsukawa Y, Ding Y, Sakai T. Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells. FEBS Lett. 437: 61-64 (1998)
27. Oakea SA, Lin SS, Bassik MC. The control of endoplasmic reticulum-initiated apoptosis by the BCL-2 family of proteins. Curr. Mol. Med. 6: 99-109 (2006)
28. van Delft M, Huang DC. How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res. 16: 203-213 (2006)